← Back to Search

Local Anesthesia for Pain Management in Facial Fractures (LAFF Trial)

Phase 2
Recruiting
Led By Amrita Hari_Raj, MD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Isolated facial fracture to the mandible and/or midface undergoing surgical repair
Be older than 18 years old
Must not have
Polytrauma (i.e. injury pattern resulting in hospital admission for multiple bony fractures outside of the face)
Patients under the age of 18
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1 month post surgery
Awards & highlights

Summary

This trial is looking at the effects of using bupivacaine nerve block during surgery on how quickly patients recover after surgery. Patients with facial fractures will either get bupivacaine or a

Who is the study for?
This trial is for patients with facial fractures requiring surgery. Participants must be eligible for the surgical procedure and able to receive injections prior to anesthesia emergence. Specific inclusion and exclusion criteria details are not provided.
What is being tested?
The study tests if bupivacaine nerve blocks help with pain management after surgery compared to saline (a placebo). Patients are randomly assigned to get either the real drug or a placebo without knowing which one they received.
What are the potential side effects?
Possible side effects of bupivacaine may include numbness, weakness, tingling sensations, dizziness, nausea, or an increased risk of infection at the injection site.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am having surgery for a broken jaw or facial bones.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I was hospitalized for multiple bone fractures not including the face.
Select...
I am younger than 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 1 month post surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 1 month post surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Impact of a perioperative bupivacaine nerve block on PACU opioid use as assessed by the amount of opioids received in morphine milligram equivalents (MMEs).
Secondary outcome measures
Impact of a perioperative bupivacaine nerve block on antiemetic use as assessed by the numbers who receive opioids and antiemetics, amount of antiemetics, pain score, frequency of emesis, and time until discharge.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Bupivacaine injectionExperimental Treatment1 Intervention
The surgeon will be provided with a 10 mL syringe, and he/she will be blinded to the contents of the syringe. The appropriate landmarks will be identified, and a 21, 25, or 27- gauge needle will be used to perform the nerve block with 0.25% bupivacaine.
Group II: Saline injectionPlacebo Group1 Intervention
The placebo sham injection will be performed in an identical fashion as the nerve block with the exception of using 10 mL of 0.9% saline injection instead of bupivacaine.

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,970 Previous Clinical Trials
2,308,553 Total Patients Enrolled
Jay Piccirillo, MDStudy DirectorWashington University School of Medicine
2 Previous Clinical Trials
180 Total Patients Enrolled
Amrita Hari_Raj, MDPrincipal InvestigatorWashington University School of Medicine
~45 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top